Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children | MicrobiomeTrials← Back to trialsNCT07235826
Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children
CompletedNAINTERVENTIONAL
Trial Details
Start: 2025-11-26Est. Completion: 2026-07-23
Enrollment target: 216 participants Locations- Università di Urbino Carlo Bo, Urbino, PU (Pesaro E Urbino), Italy
Other microbiome trials you might be interested in
TonsillitisTonsillectomyTonsillitis Recurrent
To assess the use of Suprathel 250 for mucosal reconstruction in oropharyngeal defects. The membrane will be applied aft…
Stuttgart, GermanyEst. completion Nov 30, 2026
Acute RhinitisAcute PharyngitisAcute TonsillitisAcute Sinusitis
The goal of this clinical trial is to learn if drug Jinhua Qinggan Granules (JHQG) works to treat acute upper respirator…
Karachi, PakistanCompleted Apr 24, 2026